These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. FLT3-TKD mutation in childhood acute myeloid leukemia. Liang DC; Shih LY; Hung IJ; Yang CP; Chen SH; Jaing TH; Liu HC; Wang LY; Chang WH Leukemia; 2003 May; 17(5):883-6. PubMed ID: 12750701 [TBL] [Abstract][Full Text] [Related]
3. [Mutations of the gene coding for the receptor tyrosine kinase FLT3 in acute myeloid leukemia. Significance as the disease-specific molecular marker for diagnosis, prognosis and innovative therapy approaches]. Spiekermann K; Hiddemann W; Schnittger S Dtsch Med Wochenschr; 2005 Apr; 130(16):1020-5. PubMed ID: 15830315 [No Abstract] [Full Text] [Related]
4. Dual mutations in the AML1 and FLT3 genes are associated with leukemogenesis in acute myeloblastic leukemia of the M0 subtype. Matsuno N; Osato M; Yamashita N; Yanagida M; Nanri T; Fukushima T; Motoji T; Kusumoto S; Towatari M; Suzuki R; Naoe T; Nishii K; Shigesada K; Ohno R; Mitsuya H; Ito Y; Asou N Leukemia; 2003 Dec; 17(12):2492-9. PubMed ID: 14562119 [TBL] [Abstract][Full Text] [Related]
5. Analysis of the activating mutations within the activation loop of leukemia targets Flt-3 and c-Kit based on protein homology modeling. Torrent M; Rickert K; Pan BS; Sepp-Lorenzino L J Mol Graph Model; 2004 Oct; 23(2):153-65. PubMed ID: 15363457 [TBL] [Abstract][Full Text] [Related]
6. No correlation between trisomy 13 and FLT3 duplication in acute myeloid leukemia. Powell H; Curtis A; Bown N; Taylor P Cancer Genet Cytogenet; 2005 Jan; 156(1):92-3. PubMed ID: 15588866 [No Abstract] [Full Text] [Related]
7. Inhibition of the transforming activity of FLT3 internal tandem duplication mutants from AML patients by a tyrosine kinase inhibitor. Tse KF; Allebach J; Levis M; Smith BD; Bohmer FD; Small D Leukemia; 2002 Oct; 16(10):2027-36. PubMed ID: 12357354 [TBL] [Abstract][Full Text] [Related]
8. [Mutations of growth factor receptor Flt3 in acute myeloid leukemia: transformation of myeloid cells by Ras-dependent and Ras-independent mechanisms]. Müller-Tidow C; Steur C; Mizuki M; Schwäble J; Brandts C; Berdel WE; Serve H Dtsch Med Wochenschr; 2002 Oct; 127(42):2195-200. PubMed ID: 12397548 [TBL] [Abstract][Full Text] [Related]
9. Detection of FLT3 internal tandem duplication and D835 mutations by a multiplex polymerase chain reaction and capillary electrophoresis assay. Murphy KM; Levis M; Hafez MJ; Geiger T; Cooper LC; Smith BD; Small D; Berg KD J Mol Diagn; 2003 May; 5(2):96-102. PubMed ID: 12707374 [TBL] [Abstract][Full Text] [Related]
10. Novel mutations in the FLT3 gene in adult patients with refractory acute myeloid leukemia. Choi Y; Kim HJ; Park BH; Min WS; Kim CC Leukemia; 2005 Jan; 19(1):141-3. PubMed ID: 15510198 [No Abstract] [Full Text] [Related]
11. FLT3 inhibition as tailored therapy for acute myeloid leukemia. Martinelli G; Piccaluga PP; Lo Coco F Haematologica; 2003 Jan; 88(1):4-8. PubMed ID: 12551818 [No Abstract] [Full Text] [Related]
12. Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412. Stone RM; DeAngelo DJ; Klimek V; Galinsky I; Estey E; Nimer SD; Grandin W; Lebwohl D; Wang Y; Cohen P; Fox EA; Neuberg D; Clark J; Gilliland DG; Griffin JD Blood; 2005 Jan; 105(1):54-60. PubMed ID: 15345597 [TBL] [Abstract][Full Text] [Related]
13. Point mutations in the FLT3 gene in AML. Griffin JD Blood; 2001 Apr; 97(8):2193A-2193. PubMed ID: 11290575 [No Abstract] [Full Text] [Related]
14. Low frequency of FLT3 gene internal tandem duplication and activating loop mutation in therapy-related acute myelocyticleukemia and myelodysplastic syndrome. Au WY; Fung AT; Ma ES; Liang RH; Kwong YL Cancer Genet Cytogenet; 2004 Mar; 149(2):169-72. PubMed ID: 15036894 [TBL] [Abstract][Full Text] [Related]
15. Distinct gene expression patterns associated with FLT3- and NRAS-activating mutations in acute myeloid leukemia with normal karyotype. Neben K; Schnittger S; Brors B; Tews B; Kokocinski F; Haferlach T; Müller J; Hahn M; Hiddemann W; Eils R; Lichter P; Schoch C Oncogene; 2005 Feb; 24(9):1580-8. PubMed ID: 15674343 [TBL] [Abstract][Full Text] [Related]
16. Over-expression of Flt3 induces NF-kappaB pathway and increases the expression of IL-6. Takahashi S; Harigae H; Ishii KK; Inomata M; Fujiwara T; Yokoyama H; Ishizawa K; Kameoka J; Licht JD; Sasaki T; Kaku M Leuk Res; 2005 Aug; 29(8):893-9. PubMed ID: 15978940 [TBL] [Abstract][Full Text] [Related]
17. Mutations in the receptor tyrosine kinase pathway are associated with clinical outcome in patients with acute myeloblastic leukemia harboring t(8;21)(q22;q22). Nanri T; Matsuno N; Kawakita T; Suzushima H; Kawano F; Mitsuya H; Asou N Leukemia; 2005 Aug; 19(8):1361-6. PubMed ID: 15902284 [TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of internal tandem duplication of the FLT3 gene in childhood acute myeloid leukemia. Liang DC; Shih LY; Hung IJ; Yang CP; Chen SH; Jaing TH; Liu HC; Chang WH Cancer; 2002 Jun; 94(12):3292-8. PubMed ID: 12115363 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of FLT3 mutations in pediatric non-promyelocytic acute myeloid leukemia. Kang HJ; Hong SH; Kim IH; Park BK; Han KS; Cho HI; Shin HY; Ahn HS Leuk Res; 2005 Jun; 29(6):617-23. PubMed ID: 15863200 [TBL] [Abstract][Full Text] [Related]
20. FLT3 mutations in childhood acute lymphoblastic leukemia at first relapse. Wellmann S; Moderegger E; Zelmer A; Bettkober M; von Stackelberg A; Henze G; Seeger K Leukemia; 2005 Mar; 19(3):467-8. PubMed ID: 15674414 [No Abstract] [Full Text] [Related] [Next] [New Search]